Planned Maintenance Our banking partner will perform essential maintenance from 3:30am to 7:00am on 4/12/2016 (Australian Eastern Daylight Time (AEDT)). AHPRA's account services, registration renewal for health practitioners, online graduate applications, financial transactions and other online services will be unavailable during this time. We apologise for any inconvenience.

close
Australian Health Practitioner Regulation Agency
 

Disclosure 2012/1

Date of Access to Documents: 18 January 2012

FOI Request Received by AHPRA

"I confirm that you seek access to the following documents:

  1. The development of the Board's policy dated 12 November 2010, titled "INTERIM POLICY - Use of Botulism Toxin (Botox) - please see attached document downloaded from the AHPRA website at the time of publication. This would include relevant minutes of meetings during which this topic was discussed, policy developed and signed off on; copies of consultation notes from external sources on the topic; research papers and advisory documents issued to the Board in order to reach a policy decision; submissions from various interest groups etc
  2. The amendment of the policy listed in (1) above dated 22 August 2011 in which the title of the policy was amended to "Use of Botulinum Toxin (Botox) - please see attached document downloaded from AHPRA website. This would include relevant minutes of meetings during which the topic of amendment was discussed and agreed upon; copies of consultation notes from external sources; research papers and advisory documents issued to the Board in order to reach a policy decision; submissions from various interest groups etc
  3. The Twenty-third meeting of the Dental Board of Australia – 16 September 2011 - and subsequent communique in which the Board states:

    Use of Botulinum Toxin (Botox)

    The Board would like to remind dental practitioners of its INTERIM POLICY Use of Botulinum Toxin (Botox) (the Policy) which is available on the Board's website at http://www.dentalboard.gov.au/Codes-Guidelines.aspx:

    The opinion of the Board is that injection of Botox outside of the use indicated in the Policy does not form part of the practice of dentistry. Broader use by dentists whether trained or not is not appropriate. Dental practitioners should consult the TGA and manufacturers‟ approved therapeutic use of such medications. Practitioners should also consult their professional advisers and indemnity cover for use in Australia."

    Please see attached document - this would include relevant minutes of meetings during which the topic of releasing this clarification was discussed; documents relating to the need for the clarification; copies of consultation from external sources; research papers and advisory documents issued to the Board in order to reach a decision; submissions from various interest groups etc
  4. Information relating to the selection criteria and process for the appointment of current members of the Dental Board of Australia in August 2009.
  5. Information relating to the selection criteria and process for the appointment of new Board members and what happens to existing Board members at the completion of their 3 year term - that is, do members automatically stay on the Board or are new members appointed."

Information Released

Correspondence

Meeting Minutes

 
 
 
Page reviewed 23/01/2014